Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab.
Bolton C, Harrison T, Lugogo N, Fuhlbrigge A, Hirsch I, Bengtsson T, Peterson S, Sidaway M, Garcia Gil E, Fagerås M, Da Silva CA. Bolton C, et al. Among authors: bengtsson t. ERJ Open Res. 2024 Mar 18;10(2):01025-2023. doi: 10.1183/23120541.01025-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38500798 Free PMC article.
Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials).
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Anzueto A, et al. Among authors: bengtsson t. Am J Respir Crit Care Med. 2023 Aug 15;208(4):406-416. doi: 10.1164/rccm.202306-0944OC. Am J Respir Crit Care Med. 2023. PMID: 37364283 Free PMC article. Clinical Trial.
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD.
Donohue JF, Rheault T, MacDonald-Berko M, Bengtsson T, Rickard K. Donohue JF, et al. Among authors: bengtsson t. Int J Chron Obstruct Pulmon Dis. 2023 Jul 28;18:1611-1622. doi: 10.2147/COPD.S413436. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37533771 Free PMC article. Review.
Reply to Gan et al., to Calzetta et al., and to Poor.
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Anzueto A, et al. Among authors: bengtsson t. Am J Respir Crit Care Med. 2024 Jan 15;209(2):226-228. doi: 10.1164/rccm.202309-1657LE. Am J Respir Crit Care Med. 2024. PMID: 37939377 Free PMC article. No abstract available.
Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography.
Jemaa S, Ounadjela S, Wang X, El-Galaly TC, Kostakoglu L, Knapp A, Ku G, Musick L, Sahin D, Wei MC, Yin S, Bengtsson T, De Crespigny A, Carano RAD. Jemaa S, et al. Among authors: bengtsson t. J Clin Oncol. 2024 Jun 6:JCO2301978. doi: 10.1200/JCO.23.01978. Online ahead of print. J Clin Oncol. 2024. PMID: 38843483
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis.
Talamonti E, Davegardh J, Kalinovich A, van Beek SMM, Dehvari N, Halleskog C, Bokhari HM, Hutchinson DS, Ham S, Humphrys LJ, Dijon NC, Motso A, Sandstrom A, Zacharewicz E, Mutule I, Suna E, Spura J, Ditrychova K, Stoddart LA, Holliday ND, Wright SC, Lauschke VM, Nielsen S, Scheele C, Cheesman E, Hoeks J, Molenaar P, Summers RJ, Pelcman B, Yakala GK, Bengtsson T. Talamonti E, et al. Among authors: bengtsson t. Mol Metab. 2024 May 17:101931. doi: 10.1016/j.molmet.2024.101931. Online ahead of print. Mol Metab. 2024. PMID: 38796310 Free article.
275 results